NASDAQ: ANIX - Anixa Biosciences, Inc.

半年間の収益性: -3.21%
セクタ: Healthcare

プロモーションスケジュール Anixa Biosciences, Inc.

詳細なスケジュール 簡易グラフ
Financial Markets by TradingView

会社について

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus.

さらに詳しく
Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
比較リストに追加
ウォッチリストに追加
ポートフォリオに追加
価格通知を追加

Выручка 0.00025
EBITDA -0.0106
Число акций ао 0.03098 млрд
P/S 313.47
P/BV 16.28
EV/EBITDA -7.07
Цена ао 3.13
ISIN US03528H1095
Сайт https://www.anixa.com
Валюта usd
IPO date 1987-01-01
Sector Health Care
Industry Biotechnology
Валюта отчета usd
1日あたりの価格変動: -0.33% (3.03)
週ごとの価格変動: -1.31% (3.06)
月ごとの料金変更: -9.85% (3.35)
3ヶ月間の価格変動: +3.78% (2.91)
半年間の価格変動: -3.21% (3.12)
年間の価格変動: -7.65% (3.27)
3年間の価格推移: -31.98% (4.44)
5年間の価格推移: -23.74% (3.9602)
年初からの価格変動: +4.14% (2.9)
すべてのパラメータ

過小評価

名前 意味 学年
P/S 470.6 1
P/BV 4.23 4
P/E 0 0
EV/EBITDA -8.95 0
合計: 2.5

効率

名前 意味 学年
ROA, % -38.44 0
ROE, % -40.31 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA -0.016 10
合計: 10

成長の衝動

名前 意味 学年
収益性 Revenue, % -80.91 0
収益性 Ebitda, % 3.44 1
収益性 EPS, % -46.19 0
合計: 1
さらに詳しく

機関 音量 共有, %
Vanguard Group Inc 1392906 4.37
UBS Group AG 580578 1.82
Mission Wealth Management, LLC 501168 1.57
Laird Norton Trust Company, LLC 368835 1.16
Geode Capital Management, LLC 312472 0.98
Long Focus Capital Management, LLC 165701 0.52
Blackrock Inc. 156797 0.49
State Street Corporation 108500 0.34
Bank Of New York Mellon Corporation 96654 0.3
Susquehanna International Group, LLP 73303 0.23

ETF 共有, % 年間の利益率, % 配当金, %
Dimensional U.S. Core Equity 2 ETF 0.00005 30.755198832543 1.47098
iShares Micro-Cap ETF 0.02692 36.318555985322 1.54048



スーパーバイザー 役職 支払い 生年
Dr. Amit Kumar Ph.D. CEO, Chairman & Co-Chair of CBAB 1.29M 1964 (60 年)
Mr. Michael J. Catelani CPA, MBA President, COO, CFO & Corporate Secretary 788.83k 1967 (57 年)
Mr. John Roop Senior Vice President of Engineering 275k 1950 (74 年)
Dr. Pamela D. Garzone Ph.D. Chief Development Officer & Chair Breast Cancer Clinical Advisory Board 1955 (69 年)

住所: United States, San Jose. CA, 3150 Almaden Expressway - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.anixa.com